article thumbnail

Opinion: U.S. taxpayers should stop funding clinical trials of industry-owned drugs

STAT

  I worked closely with NCI’s Investigational Drug Branch (IDB) from 1990-2016, including as a principal investigator of one of only six contracts with NCI to conduct Phase 1 clinical trials from 1990-1995, and serving as co-chair of NCI’s Investigational Drug Steering Committee from 2005-2008. At this stage, U.S.

article thumbnail

New biosimilar pathways – key takeaways from the EMA’s draft reflection paper

European Pharmaceutical Review

Guideline On Similar Biological Medicinal Products Containing Biotechnology-Derived Proteins As Active Substance: Non-Clinical and Clinical Issues, EMEA/CHMP/BMWP/42832/2005 Rev1. European Medicines Agency. Guillen E, Ekman N, Barry S, et al. A Data Driven Approach to Support Tailored Clinical Programs for Biosimilar Monoclonal Antibodies.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Indian Society for Clinical Research appoints Dr Seema Pai as President

Express Pharma

” ISCR, established in 2005, represents professionals involved in clinical research in India. I extend my heartfelt congratulations to Dr Seema Pai, Anirban Roychowdhury, and Amita Bhave, and I look forward to seeing ISCR scale even greater heights under their stewardship of the society.”

89
article thumbnail

Brand Name Search

RX Note

2005 SPS - Prescribing by generic or brand name in primary care SPS - Example medicines to prescribe by brand name in primary care

article thumbnail

Nutraceuticals 2025: Mapping growth, innovation, and consumer-centric trends

Express Pharma

The nutraceutical market began to gain traction around 2005-2010, growing steadily since then. People are increasingly leaning towards prevention and preventive care rather than relying solely on therapeutic medications. However, the COVID-19 pandemic served as a significant turning point, increasing awareness about health and wellness.

Diabetes 105
article thumbnail

Beyond instruments: streamlining process technology implementation in biopharmaceutical manufacturing

European Pharmaceutical Review

International Council for Harmonisation (ICH), 2005. Q2(R2) Validation of Analytical Procedures: Text and Methodology. International Council for Harmonisation (ICH), 2009. Q8(R2) Pharmaceutical Development. Q9 Quality Risk Management. International Council for Harmonisation (ICH), 2008. Q10 Pharmaceutical Quality System.

article thumbnail

Regulating decentralised manufacturing in the UK – a legal perspective

European Pharmaceutical Review

Under the Blood Safety and Quality Regulations 2005. [Internet] UK Government. Available from: [link] Human Medicines Regulations 2012 and Medicines for Human Use (Clinical Trials) Regulations 2004. Under the Human Tissue Act 2004. Internet] European Parliament.